Pharmaceutical Services

Global law firm Norton Rose Fulbright has advised Profil Institut für Stoffwechselforschung GmbH (Profil) on its acquisition of US based clinical research organisation Tranquil Clinical and Research Consulting Services, LLC. The transaction involved a reverse subsidiary merger and the issuance of rollover equity in the Profil parent company in Germany to the seller. It establishes

InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, announces the acquisition of PhenoVista Biosciences, Inc., a premier provider of high-content imaging and phenotypic assay technologies based in San Diego, California. The acquisition marks an important new chapter for PhenoVista Biosciences, enabling the company to

Ennov (the “Company”), a global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, announces a strategic growth investment led by Bregal Sagemount (“Sagemount”), a leading growth-focused private equity firm, with participation from Ardian, a global private investment firm. Founded and headquartered in Paris, Ennov provides a unified compliance

Lexitas Pharma Services, a portfolio company of QHP Capital, is pleased to announce the closing of its acquisition of Erie Retina Research—one of the nation’s premier retina research centers led by Dr. David Almeida, MD, MBA, PhD—which will operate as a wholly owned subsidiary of Lexitas. As part of the transaction, Lexitas also acquired CASExERIE,